ACADIA PHARMACEUTICALS INC Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q1 2022 to Q3 2024
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
Acadia Pharmaceuticals Inc quarterly/annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q1 2022 to Q3 2024.
- Acadia Pharmaceuticals Inc Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending September 30, 2024 was 0.21 pure, unchanged year-over-year.
- Acadia Pharmaceuticals Inc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2019 was 0.21 pure, unchanged from 2018.
- Acadia Pharmaceuticals Inc annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2018 was 0.21 pure, a 40% decline from 2017.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, YoY Quarterly Growth (%)